CARDINAL HEALTH, INC. UNDERWRITING AGREEMENT February 14, 2024Underwriting Agreement • February 20th, 2024 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledFebruary 20th, 2024 Company Industry JurisdictionThe Securities will be issued pursuant to the indenture (the “Base Indenture”), dated as of June 2, 2008, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture (together with the Base Indenture, the “Indenture”), dated as of February 20, 2024, between the Company and the Trustee. If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives,” as used herein, shall each be deemed to refer to such firm or firms.
CARDINAL HEALTH, INC. UNDERWRITING AGREEMENT June 16, 2015Underwriting Agreement • June 23rd, 2015 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledJune 23rd, 2015 Company Industry JurisdictionThe Securities will be issued pursuant to the indenture, dated as of June 2, 2008, as supplemented by the Officers’ Certificate, dated June 23, 2015 (as so supplemented, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives,” as used herein, shall each be deemed to refer to such firm or firms.
UNDERWRITING AGREEMENT November 7, 2014Underwriting Agreement • November 10th, 2014 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledNovember 10th, 2014 Company Industry JurisdictionThe Securities will be issued pursuant to the indenture, dated as of June 2, 2008, as supplemented by the Officers’ Certificate, dated November 19, 2014 (as so supplemented, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives,” as used herein, shall each be deemed to refer to such firm or firms.
CARDINAL HEALTH, INC. UNDERWRITING AGREEMENT February 19, 2013Underwriting Agreement • February 22nd, 2013 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledFebruary 22nd, 2013 Company Industry JurisdictionThe Securities will be issued pursuant to the indenture, dated as of June 2, 2008, as supplemented by the Officers’ Certificate, dated February 22, 2013 (as so supplemented, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives,” as used herein, shall each be deemed to refer to such firm or firms.
CARDINAL HEALTH, INC. UNDERWRITING AGREEMENT May 16, 2012Underwriting Agreement • May 21st, 2012 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledMay 21st, 2012 Company Industry JurisdictionThe Securities will be issued pursuant to the indenture, dated as of June 2, 2008 (the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives,” as used herein, shall each be deemed to refer to such firm or firms.
CARDINAL HEALTH, INC. UNDERWRITING AGREEMENT December , 2005Underwriting Agreement • December 12th, 2005 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledDecember 12th, 2005 Company Industry JurisdictionCardinal Health, Inc., an Ohio corporation (the “Company”), proposes to sell to underwriters named in Schedule II hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”), the principal amount of its securities (the “Securities”) identified in Schedule I hereto issued under an indenture (the “Indenture”) dated as of April 18, 1997, between the Company and JP Morgan Trust Company, National Association (successor to Bank One, N.A., formerly known as Bank One, Columbus, N.A.), as trustee (the “Trustee”). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms “Underwriters” and “Representatives”, as used herein, shall each be deemed to refer to such firm or firms.